What Is Mounjaro® and How Does It Work?
Dual Hormone Action
Activates both GLP-1 and GIP receptors to support appetite control, insulin response, and metabolic regulation.
Blood Sugar Support
Helps improve blood glucose control by enhancing insulin secretion when blood sugar levels are elevated.
Weight Management
May reduce hunger, increase fullness, and support meaningful weight reduction when used with lifestyle changes.
Clinically Proven Results for Eligible Patients
Mounjaro® has been studied in large-scale clinical trials for both type 2 diabetes management and chronic weight management. In the SURMOUNT-1 clinical trial published in the New England Journal of Medicine, adults receiving tirzepatide once weekly together with lifestyle intervention achieved substantial weight reduction compared with placebo.
Up to 22.5%
Maximum body weight reduction reported in SURMOUNT-1
20.9%
Average body weight reduction in the 15 mg group
Once Weekly
Subcutaneous injection schedule
Mounjaro® may be considered for:
✓ Adults with type 2 diabetes who need blood sugar management
✓ Adults with obesity, typically BMI ≥ 30 kg/m²
✓ Adults who are overweight, typically BMI ≥ 27 kg/m², with at least one weight-related health condition
✓ Individuals with pre-diabetes, insulin resistance, high blood pressure, dyslipidaemia, sleep apnoea, or cardiovascular risk factors
✓ People seeking doctor-supervised metabolic and weight management
Individual results may vary. A doctor consultation is required to assess suitability, HbA1c level, BMI, medical history, current medications, kidney function, and treatment goals.
Diabetes, Dosage and Safety Information
Can people with type 2 diabetes use Mounjaro®?
Yes. Mounjaro® was originally developed for type 2 diabetes management and may help improve blood sugar control when used under medical supervision. It may be especially suitable for eligible patients who need support with both HbA1c control and body weight management.
How is Mounjaro® used?
Mounjaro® is administered once weekly by subcutaneous injection. Treatment usually starts at a low dose and may be gradually increased depending on individual response, treatment goals, tolerability, and doctor recommendation.
What are the possible side effects?
Common side effects may include nausea, diarrhoea, constipation, vomiting, abdominal discomfort, reduced appetite, indigestion, or bloating. People taking insulin, sulfonylureas, or other glucose-lowering medications should inform their doctor, as dosage adjustments may be needed to reduce the risk of low blood sugar.